Comprehensive Evaluation of Metabolism and the Contribution of the Hepatic First-Pass Effect in the Bioavailability of Glabridin in Rats
Journal of Agricultural and Food Chemistry · 01.02.2023 · 71 (4) · 1944-1956
DOI: 10.1021/acs.jafc.2c06460 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Agricultural and Food Chemistry, online erschienen am 17.01.2023. Verfasst von Like Xie und 12 weiteren Autor:innen. Beteiligte Einrichtung: Key Lab of Drug Metabolism and Pharmacokinetics, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, Jiangsu210009, …. Hauptthemen laut MEDLINE: Isoflavones. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: Chinese Academy of Medical Sciences.
Abstract (Originalsprache)
Glabridin is a bioactive isoflavan, which has a wide range of biological properties and is widely used in the market of health products and dietary supplements. However, the transformation pathway of glabridin in vivo is unclear, and the bioavailability is controversial among different studies. Therefore, a new HPLC-Q-TOF method was developed to analyze and identify the prototype and metabolites of glabridin in rats. A total of 63 compounds were identified, including hydroxylation, demethylation, acetylation, demethylation to carboxylation, glucuronidation, and sulfate conjugation, and 43 of which were new metabolites that had not been reported. Additionally, our study verified that the oral bioavailability of glabridin was 6.63 ± 2.29% in rats. Furthermore, we found that the hepatic first-pass effect was 62.12 ± 15.7% for glabridin. These results indicated that a high hepatic first-pass effect and extensive metabolism of glabridin in vivo may lead to its limited oral bioavailability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Lab of Drug Metabolism and Pharmacokinetics, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, Jiangsu210009, China.
- Instrumental Analysis Center, China Pharmaceutical University, Nanjing, Jiangsu210009, China.
- School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu210009, China.
- Department of Pharmacy, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu210009, China.
ORCID-Profile: Like Xie, Zhipeng Diao, Jianguo Sun
Förderung
- Chinese Academy of Medical Sciences
Zitieren
APA
Xie, L., Diao, Z., Xia, J., Zhang, J., Xu, Y., Wu, Y., Liu, Z., Jiang, C., Peng, Y., Song, Z., Wang, G., Zhu, J., & Sun, J. (2023). Comprehensive Evaluation of Metabolism and the Contribution of the Hepatic First-Pass Effect in the Bioavailability of Glabridin in Rats. Journal of Agricultural and Food Chemistry, 71(4), 1944-1956. https://doi.org/10.1021/acs.jafc.2c06460
Vancouver
Xie L, Diao Z, Xia J, Zhang J, Xu Y, Wu Y, et al. Comprehensive Evaluation of Metabolism and the Contribution of the Hepatic First-Pass Effect in the Bioavailability of Glabridin in Rats. Journal of Agricultural and Food Chemistry. 2023;71(4):1944-1956. doi:10.1021/acs.jafc.2c06460
BibTeX
@article{Xie2023,
author = {Xie, Like and Diao, Zhipeng and Xia, Jing and Zhang, Jing and Xu, Yao and Wu, Yapeng and Liu, Zihou and Jiang, Chengwen and Peng, Ying and Song, Zhe and Wang, Guangji and Zhu, Junrong and Sun, Jianguo},
title = {Comprehensive Evaluation of Metabolism and the Contribution of the Hepatic First-Pass Effect in the Bioavailability of Glabridin in Rats},
journal = {Journal of Agricultural and Food Chemistry},
year = {2023},
volume = {71},
number = {4},
pages = {1944--1956},
doi = {10.1021/acs.jafc.2c06460}
}
EUVIMED